Xencor
An Associate Scientist 1 at Xencor leads research and development efforts in antibody discovery, engineering, and characterization within the Protein Sciences department. The role involves designing comprehensive research studies, executing cell-based and flow cytometry assays, and utilizing automation and AI tools to optimize experimental workflows. Candidates will also provide scientific oversight, manage project analysis, and may supervise junior staff to advance the company's clinical-stage bispecific therapeutics pipeline.
Headquarters
Pasadena, California, United States
Company Size
201-500 employees
Founded
1997
Xencor is a clinical-stage biopharmaceutical company that designs engineered proteins to create novel biologic medicines. Using proprietary protein-design platforms (including XmAb Fc engineering and cytokine/antibody engineering), Xencor builds next‑generation monoclonal antibodies, bispecifics and cytokine therapeutics with improved potency, half‑life and safety. The company advances an internal pipeline across oncology and immune‑mediated diseases while partnering with other biopharma organizations to discover and develop therapeutics. Xencor emphasizes rational protein design and translational science to deliver differentiated medicines to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Xencor.
21% below the average for this role
Research Associate
AlivaMab Discovery Services
Cell-Based Assay Senior Scientist, Discovery Biologics
MSD
Senior Associate Scientist - Discovery Research, Regeneron Cell Medicines
Regeneron Pharmaceuticals
Senior Research Associate*
bighatbiosciences
Research Bioassay Scientist
CSL Behring Australia
Scientist, Immuno-Oncology
Systimmune